Australia markets open in 1 hour 56 minutes

Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
23.63+1.09 (+4.84%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.77B
Enterprise value 3.25B
Trailing P/E 16.64
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.98
Price/book (mrq)2.24
Enterprise value/revenue 1.71
Enterprise value/EBITDA 10.69

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-39.35%
S&P500 52-week change 324.19%
52-week high 344.66
52-week low 316.49
50-day moving average 321.22
200-day moving average 326.05

Share statistics

Avg vol (3-month) 32.12M
Avg vol (10-day) 33.29M
Shares outstanding 5159.64M
Implied shares outstanding 6159.64M
Float 894.77M
% held by insiders 164.52%
% held by institutions 15.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 42.12%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 435.21%
Dividend date 3N/A
Ex-dividend date 424 May 2023
Last split factor 21.3:1
Last split date 324 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.42%
Operating margin (ttm)8.10%

Management effectiveness

Return on assets (ttm)4.73%
Return on equity (ttm)11.28%

Income statement

Revenue (ttm)1.42B
Revenue per share (ttm)8.93
Quarterly revenue growth (yoy)-58.90%
Gross profit (ttm)N/A
EBITDA 220.2M
Net income avi to common (ttm)190.9M
Diluted EPS (ttm)1.42
Quarterly earnings growth (yoy)-54.10%

Balance sheet

Total cash (mrq)510.24M
Total cash per share (mrq)3.19
Total debt (mrq)37.31M
Total debt/equity (mrq)1.96%
Current ratio (mrq)2.19
Book value per share (mrq)10.73

Cash flow statement

Operating cash flow (ttm)197.56M
Levered free cash flow (ttm)118.19M